Advertisement
Research Article Free access | 10.1172/JCI119369
Department of Medicine, School of Medicine, College of Letters and Sciences, University of California, Los Angeles 90095, USA. mnavab@medicine.medsch.ucla.edu
Find articles by Navab, M. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, College of Letters and Sciences, University of California, Los Angeles 90095, USA. mnavab@medicine.medsch.ucla.edu
Find articles by Hama-Levy, S. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, College of Letters and Sciences, University of California, Los Angeles 90095, USA. mnavab@medicine.medsch.ucla.edu
Find articles by Van Lenten, B. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, College of Letters and Sciences, University of California, Los Angeles 90095, USA. mnavab@medicine.medsch.ucla.edu
Find articles by Fonarow, G. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, College of Letters and Sciences, University of California, Los Angeles 90095, USA. mnavab@medicine.medsch.ucla.edu
Find articles by Cardinez, C. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, College of Letters and Sciences, University of California, Los Angeles 90095, USA. mnavab@medicine.medsch.ucla.edu
Find articles by Castellani, L. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, College of Letters and Sciences, University of California, Los Angeles 90095, USA. mnavab@medicine.medsch.ucla.edu
Find articles by Brennan, M. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, College of Letters and Sciences, University of California, Los Angeles 90095, USA. mnavab@medicine.medsch.ucla.edu
Find articles by Lusis, A. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, College of Letters and Sciences, University of California, Los Angeles 90095, USA. mnavab@medicine.medsch.ucla.edu
Find articles by Fogelman, A. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, College of Letters and Sciences, University of California, Los Angeles 90095, USA. mnavab@medicine.medsch.ucla.edu
Find articles by La Du, B. in: JCI | PubMed | Google Scholar
Published April 15, 1997 - More info
We have examined the effects of mildly oxidized LDL and atherosclerosis on the levels of two proteins associated with HDL; apolipoprotein J (apoJ), and paraoxonase (PON). On an atherogenic diet, PON activity decreased by 52%, and apoJ levels increased 2.8-fold in fatty streak susceptible mice, C57BL/6J (BL/6), but not in fatty streak resistant mice, C3H/HeJ (C3H). Plasma PON activity was also significantly decreased, and apoJ levels were markedly increased in apolipoprotein E knockout mice on the chow diet, resulting in a 9.2-fold increase in the apoJ/PON ratio as compared to controls. Furthermore, a dramatic increase in the apoJ/PON ratio (over 100-fold) was observed in LDL receptor knockout mice when they were fed a 0.15%-cholesterol-enriched diet. Injection of mildly oxidized LDL (but not native LDL) into BL/6 mice (but not in C3H mice) on a chow diet resulted in a 59% decrease in PON activity (P < 0.01) and a 3.6-fold increase in apoJ levels (P < 0.01). When an acute phase reaction was induced in rabbits, or the rabbits were placed on an atherogenic diet, hepatic mRNA for apoJ was increased by 2.7-fold and 2.8-fold, respectively. Treatment of HepG2 cells in culture with mildly oxidized LDL (but not native LDL) resulted in reduced mRNA levels for PON (3.0-fold decrease) and increased mRNA levels for apoJ (2.0-fold increase). In normolipidemic patients with angiographically documented coronary artery disease who did not have diabetes and were not on lipid-lowering medication (n = 14), the total cholesterol/HDL cholesterol ratio was 3.1+/-0.9 as compared to 2.9+/-0.4 in the controls (n = 19). This difference was not statistically significant. In contrast, the apoJ/PON ratio was 3.0+/-0.4 in the patients compared to 0.72+/-0.2 in the controls (P < 0.009). In a subset of these normolipidemic patients (n = 5), the PON activity was low (48+/-6.6 versus 98+/-17 U/ml for controls; P < 0.009), despite similar normal HDL levels, and the HDL from these patients failed to protect against LDL oxidation in co-cultures of human artery wall cells. We conclude that: (a) mildly oxidized LDL can induce an increased apoJ/PON ratio, and (b) the apoJ/PON ratio may prove to be a better predictor of atherosclerosis than the total cholesterol/HDL cholesterol ratio.